Ambetter Clinical Coverage/Medical Policy Updates
Ambetter from Arkansas Health & Wellness updates a select number of clinical coverage policies each month, ensuring the reviewal of all policies on an annual basis.
V1.2025 CG Testing: Aortopathies and Connective Tissue Disorders (PDF)
V1.2025 CG Testing: Cardiac Disorders (PDF)
V1.2025 CG Testing: Dermatologic Conditions (PDF)
V1.2025 CG Testing: Epilepsy, Neurodegenerative, and Neuromuscular Conditions (PDF)
V1.2025 CG Testing: Exome and Genome Sequencing for the Diagnosis of Genetic Disorders (PDF)
V1.2025 CG Testing: Eye Disorders (PDF)
V1.2025 CG Testing: General Approach to Genetic and Molecular Testing (PDF)
V1.2025 CG Testing: Hearing Loss (PDF)
V1.2025 CG Testing: Hematologic Conditions Non-Cancerous (PDF)
V1.2025 CG Testing: Hereditary Cancer Susceptibility (PDF)
V1.2025 CG Testing: Immune, Autoimmune, and Rheumatoid Disorders (PDF)
V1.2025 CG Testing: Kidney Disorders (PDF)
V1.2025 CG Testing: Lung Disorders (PDF)
V1.2025 CG Testing: Metabolic, Endocrine, and Mitochondrial Disorders (PDF)
V1.2025 CG Testing: Prenatal Cell-Free DNA Testing (PDF)
V1.2025 CG Oncology: Algorithmic Testing (PDF)
V1.2025 CG Oncology: Cancer Screening (PDF)
V1.2025 CG Oncology: Circulating Tumor DNA and Circulating Tumor Cells (Liquid Biopsy) (PDF)
V1.2025 CG Oncology: Cytogenetic Testing (PDF)
V1.2025 CG Oncology: Molecular Analysis of Solid Tumors and Hematologic Malignancies (PDF)
V1.2025 CG Testing: Preimplantation Genetic Testing (PDF)
V1.2025 CG Testing: Prenatal and Preconception Carrier Screening (PDF)
V1.2025 CG Testing: Prenatal Diagnosis (via Amniocentesis, CVS, or PUBS) and Pregnancy Loss (PDF)
V2.2024 CG Testing: Skeletal Dysplasia and Rare Bone Disorders (PDF)
V1.2025 CG Testing: Gastroenterologic Disorders Non-Cancerous (PDF)
V1.2025 CG Testing: Pharmacogenetics (Version A) (PDF)
V1.2025 CG Testing: Aortopathies and Connective Tissue Disorders (PDF)